BTIM Corp. increased its position in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 13.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 240,571 shares of the medical technology company’s stock after buying an additional 29,029 shares during the period. BTIM Corp. owned 0.37% of Hill-Rom Holdings worth $19,152,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of HRC. Meadow Creek Investment Management LLC boosted its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock worth $120,000 after buying an additional 64 shares in the last quarter. Neuburgh Advisers LLC boosted its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock worth $165,000 after buying an additional 88 shares in the last quarter. State Treasurer State of Michigan boosted its stake in shares of Hill-Rom Holdings by 0.4% in the first quarter. State Treasurer State of Michigan now owns 24,150 shares of the medical technology company’s stock worth $1,705,000 after buying an additional 100 shares in the last quarter. Tyers Asset Management LLC boosted its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Tyers Asset Management LLC now owns 2,968 shares of the medical technology company’s stock worth $210,000 after buying an additional 112 shares in the last quarter. Finally, Flinton Capital Management LLC boosted its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Flinton Capital Management LLC now owns 3,604 shares of the medical technology company’s stock worth $254,000 after buying an additional 136 shares in the last quarter. 84.00% of the stock is currently owned by hedge funds and other institutional investors.
Hill-Rom Holdings Inc (NYSE:HRC) opened at 75.92 on Tuesday. The stock has a market capitalization of $5.00 billion, a P/E ratio of 44.24 and a beta of 1.22. The firm’s 50-day moving average is $80.60 and its 200 day moving average is $72.15. Hill-Rom Holdings Inc has a 12-month low of $50.50 and a 12-month high of $84.65.
Hill-Rom Holdings (NYSE:HRC) last issued its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The firm had revenue of $689.10 million for the quarter, compared to analysts’ expectations of $695.50 million. During the same quarter last year, the business earned $0.81 earnings per share. The company’s revenue was up 5.1% compared to the same quarter last year. Equities research analysts anticipate that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is currently 41.62%.
Several analysts have recently commented on the stock. BidaskClub upgraded shares of Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research note on Sunday. Zacks Investment Research cut shares of Hill-Rom Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Stifel Nicolaus restated a “buy” rating and issued a $84.00 target price on shares of Hill-Rom Holdings in a research note on Sunday, July 30th. Cantor Fitzgerald set a $86.00 target price on shares of Hill-Rom Holdings and gave the stock a “hold” rating in a research note on Friday, July 28th. Finally, Needham & Company LLC reduced their price objective on shares of Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating for the company in a research note on Friday, July 28th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. Hill-Rom Holdings has an average rating of “Buy” and an average price target of $88.17.
In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 2,078 shares of the firm’s stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total transaction of $150,239.40. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Andreas G. Frank sold 10,660 shares of Hill-Rom Holdings stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $78.62, for a total value of $838,089.20. Following the transaction, the senior vice president now owns 28,988 shares in the company, valued at approximately $2,279,036.56. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
